Medicine & Life Sciences
Tuberculosis
100%
rifapentine
51%
bedaquiline
44%
Pyrazinamide
42%
pretomanid
41%
Mycobacterium tuberculosis
39%
Rifampin
39%
Moxifloxacin
34%
Pharmaceutical Preparations
34%
Isoniazid
29%
Multidrug-Resistant Tuberculosis
27%
Linezolid
25%
Mycobacterium ulcerans
25%
Buruli Ulcer
22%
Clofazimine
19%
Pharmacokinetics
16%
Mycobacterium abscessus
14%
Therapeutics
14%
PNU-100480
14%
Latent Tuberculosis
13%
Lung
12%
Oxazolidinones
11%
rifamycin SV
11%
Aerosols
10%
Anti-Bacterial Agents
10%
Lactams
9%
Duration of Therapy
9%
Infections
9%
In Vitro Techniques
9%
Guinea Pigs
9%
Streptomycin
9%
OPC-67683
9%
6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl)benzyl) imidazo(1,2-a)pyridine-3-carboxamide
8%
Animal Models
7%
pyrazinoic acid
7%
Pulmonary Tuberculosis
7%
Meropenem
7%
Extensively Drug-Resistant Tuberculosis
7%
Diarylquinolines
6%
Recurrence
6%
Rifamycins
6%
Clinical Trials
6%
Clarithromycin
6%
Drug Development
6%
Drug Combinations
6%
Granuloma
5%
Fluoroquinolones
5%
Nitroimidazoles
5%
Rifabutin
5%
Drug Therapy
5%